|
DNAJA2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.27760005194955E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.72929999992166E-07 |
| Normal-vs-Stage2 |
7.623600E-02 |
| Normal-vs-Stage3 |
9.80169945208331E-10 |
| Normal-vs-Stage4 |
4.04010158661094E-11 |
| Stage1-vs-Stage2 |
2.486200E-02 |
| Stage1-vs-Stage3 |
2.000400E-02 |
| Stage1-vs-Stage4 |
4.355400E-03 |
| Stage2-vs-Stage3 |
1.400070E-03 |
| Stage2-vs-Stage4 |
2.369800E-04 |
| Stage3-vs-Stage4 |
4.686200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.40239980423496E-10 |
| Normal-vs-AfricanAmerican |
2.736600E-03 |
| Normal-vs-Asian |
7.53529999508729E-08 |
| Caucasian-vs-AfricanAmerican |
4.119000E-01 |
| Caucasian-vs-Asian |
6.920400E-01 |
| AfricanAmerican-vs-Asian |
3.021400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.48389999977373E-07 |
| Normal-vs-Female |
2.77530000092341E-08 |
| Male-vs-Female |
6.500600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.97390000000741E-06 |
| Normal-vs-Age(41-60Yrs) |
6.02399996552094E-09 |
| Normal-vs-Age(61-80Yrs) |
9.45439999955333E-07 |
| Normal-vs-Age(81-100Yrs) |
5.028800E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.427810E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.683200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.896810E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.086400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.974200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.727600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.213300E-04 |
| Classical-VS-Follicular |
8.338400E-03 |
| Classical-VS-Other |
8.635400E-01 |
| Classical-VS-Normal |
1.33030000015744E-07 |
| Tall-VS-Follicular |
2.71969999998678E-06 |
| Tall-VS-Other |
1.304400E-01 |
| Tall-VS-Normal |
3.004999582501E-10 |
| Follicular-VS-Other |
3.545200E-01 |
| Follicular-VS-Normal |
1.128350E-02 |
| Other-VS-Normal |
1.480400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.24660000047727E-07 |
| Normal-vs-N1 |
3.12599945928582E-11 |
| N0-vs-N1 |
2.764500E-03 |
|
|
